Just saw the latest disclosure from Motley Fool healthcare analyst Keith Speights. He is currently holding positions in AbbVie, Bristol Myers Squibb, and Pfizer. The firm is actively recommending those three stocks right now, along with Eli Lilly and Johnson & Johnson.